Floatz logo

Tapentadol

Sciatica

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Small moleculePhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Sciatica cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
University of Miami
Phase 4BBB
LIDOCAINE
C.L.A.Vleggeert-Lankamp
Phase 4BBB
NEPENTHE
Akdeniz University
Phase 4BB
Naproxen
Ostfold Hospital Trust
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Hadassah Medical Organization
Phase 4BB

View all 26 →

Same molecule, other indications

Tapentadol is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
osteoarthritisDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →